Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
EGFR突变型III-pN2期肺腺癌辅助TKI治疗与TKI联合化疗的疗效比较
期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol28020135
Li, Qiwen; Ma, Li; Qiu, Bo; Wen, Yuzhi; Liang, Wenhua; Hu, Wanming; Chen, Naibin; Zhang, Tian; Xu, Shuangbing; Chen, Lingjuan; Guo, Minzhang; Zhao, Yi; Liu, Songran; Guo, Jinyu; Wang, Junye; Wang, Siyu; Wang, Xin; Pang, Qingsong; Long, Hao; Liu, Hui